Translated title of the contribution | Antithrombin Alfa (ATryn®) Therapy in Hereditary Antithrombin (AT) Deficient Patients: A Phase 3 Study of Prophylactic Intravenous Administration in High Risk Situations |
---|---|
Original language | English |
Pages (from-to) | 616 - 612 |
Journal | Thrombosis and Haemostasis |
Volume | 99 |
Publication status | Published - 2008 |
Antithrombin Alfa (ATryn®) Therapy in Hereditary Antithrombin (AT) Deficient Patients: A Phase 3 Study of Prophylactic Intravenous Administration in High Risk Situations
[No Value] Tiede A, J, Tait RC, Shaffer D, Baudo F, Boneu B, Dempfle C, Horellou M, Klamroth R, Lazarchick, AD Mumford, [No Value] Schulman S, Bonfiglio J, Frieling J, Conard J, von Depka M.
Research output: Contribution to journal › Article (Academic Journal) › peer-review